TSHR CRE-Luc HEK293
CBP71485
| I. Background | |
|
G 蛋白偶聯(lián)受體（GPCR）是跨膜蛋白受體，其特征是配體數(shù)量可變，包括內(nèi)源性神 經(jīng)遞質(zhì)和激素，也包括外源性天然和人工化合物。激動(dòng)劑與受體結(jié)合后會(huì)觸發(fā)信號(hào)通路的 激活；而拮抗劑則會(huì)阻礙激動(dòng)劑介導(dǎo)的受體激活。反向激動(dòng)劑除像拮抗劑一樣干擾激動(dòng)劑 外，還會(huì)抑制受體的組成活性。 |
|
| II. Description | |
|
TSHR CRE-Luc HEK293 報(bào)告基因藥靶模型很好的模擬了體內(nèi) TSHR 的信號(hào)轉(zhuǎn)導(dǎo)過程，原理見下圖所示。 |
|
 Figure 1. TSHR CRE-Luc HEK293細(xì)胞模型原理圖
|
|
| III. Introduction | |
| Expressed gene: | TSHR |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | DMEM+10%FBS+2 μg/ml puromycin+200 μg/ml hygromycin |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Functional assay for TSHR |
| Transducer: | Gs |
IV. Representative Data Figure 2. Recombinant TSHR CRE-Luc HEK293 stably expressing TSHR.  Figure 3. Dose Response of Agonists in TSHR CRE-Luc HEK293(C31). |
|
